Artwork

ืชื•ื›ืŸ ืžืกื•ืคืง ืขืœ ื™ื“ื™ Flot.bio. ื›ืœ ืชื•ื›ืŸ ื”ืคื•ื“ืงืืกื˜ื™ื ื›ื•ืœืœ ืคืจืงื™ื, ื’ืจืคื™ืงื” ื•ืชื™ืื•ืจื™ ืคื•ื“ืงืืกื˜ื™ื ืžื•ืขืœื™ื ื•ืžืกื•ืคืงื™ื ื™ืฉื™ืจื•ืช ืขืœ ื™ื“ื™ Flot.bio ืื• ืฉื•ืชืฃ ืคืœื˜ืคื•ืจืžืช ื”ืคื•ื“ืงืืกื˜ ืฉืœื”ื. ืื ืืชื” ืžืืžื™ืŸ ืฉืžื™ืฉื”ื• ืžืฉืชืžืฉ ื‘ื™ืฆื™ืจื” ืฉืœืš ื”ืžื•ื’ื ืช ื‘ื–ื›ื•ื™ื•ืช ื™ื•ืฆืจื™ื ืœืœื ืจืฉื•ืชืš, ืืชื” ื™ื›ื•ืœ ืœืขืงื•ื‘ ืื—ืจ ื”ืชื”ืœื™ืš ื”ืžืชื•ืืจ ื›ืืŸ https://he.player.fm/legal.
Player FM - ืืคืœื™ืงืฆื™ื™ืช ืคื•ื“ืงืืกื˜
ื”ืชื—ืœ ื‘ืžืฆื‘ ืœื ืžืงื•ื•ืŸ ืขื ื”ืืคืœื™ืงืฆื™ื” Player FM !

Christina Takke, V-Bio Ventures ๐Ÿ‡ง๐Ÿ‡ช | Wonder VC Woman | E17

43:45
 
ืฉืชืคื•
 

Manage episode 424077296 series 3470295
ืชื•ื›ืŸ ืžืกื•ืคืง ืขืœ ื™ื“ื™ Flot.bio. ื›ืœ ืชื•ื›ืŸ ื”ืคื•ื“ืงืืกื˜ื™ื ื›ื•ืœืœ ืคืจืงื™ื, ื’ืจืคื™ืงื” ื•ืชื™ืื•ืจื™ ืคื•ื“ืงืืกื˜ื™ื ืžื•ืขืœื™ื ื•ืžืกื•ืคืงื™ื ื™ืฉื™ืจื•ืช ืขืœ ื™ื“ื™ Flot.bio ืื• ืฉื•ืชืฃ ืคืœื˜ืคื•ืจืžืช ื”ืคื•ื“ืงืืกื˜ ืฉืœื”ื. ืื ืืชื” ืžืืžื™ืŸ ืฉืžื™ืฉื”ื• ืžืฉืชืžืฉ ื‘ื™ืฆื™ืจื” ืฉืœืš ื”ืžื•ื’ื ืช ื‘ื–ื›ื•ื™ื•ืช ื™ื•ืฆืจื™ื ืœืœื ืจืฉื•ืชืš, ืืชื” ื™ื›ื•ืœ ืœืขืงื•ื‘ ืื—ืจ ื”ืชื”ืœื™ืš ื”ืžืชื•ืืจ ื›ืืŸ https://he.player.fm/legal.

Weโ€™re in San Sebastiรกn ๐Ÿ‡ช๐Ÿ‡ธ with one of the top VCs in Europe, Christina Takke from V-Bio Ventures.

We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 2022.

๐Ÿ’Ž ABOUT THE SPEAKER

Christina co-founded V-Bio Ventures in 2015 and is now the Managing Partner. Before this, she was a leader in the European Venture Capital world with 15 years of experience. She has been a partner at Forbion Capital Partners where she led many successful investments in biopharma and pharma companies.

๐Ÿ”— LINKS MENTIONED

- Lean years for company creation in Europe? - BioVox, Sep 2023 - https://biovox.eu/lean-years-for-company-creation-in-europe/

๐Ÿ“œ TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/christina-takke-v-bio-ventures/

๐Ÿ’ธ DONATE

We welcome donations from individuals and businesses to support our more content creation: https://www.paypal.me/PhilipHemmeโญ๏ธ

SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!

๐Ÿซถ FOLLOW US

- Newsletter: http://eepurl.com/h_fnmH

- LinkedIn: https://www.linkedin.com/company/flot-bio/

- X (Twitter): https://x.com/FlotBio

๐Ÿ™ LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

๐ŸŽ™๏ธ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.

โฐ TIMESTAMPS

[00:00:00] Intro

[00:02:03] Top VC woman in biotech

[00:08:36] European background

[00:13:49] Investing in Argenx at the start

[00:20:26] V-Bio story

[00:25:09] Tech transfer

[00:35:44] Company creation drop

[00:42:39] Thanks for listening

  continue reading

24 ืคืจืงื™ื

Artwork
iconืฉืชืคื•
 
Manage episode 424077296 series 3470295
ืชื•ื›ืŸ ืžืกื•ืคืง ืขืœ ื™ื“ื™ Flot.bio. ื›ืœ ืชื•ื›ืŸ ื”ืคื•ื“ืงืืกื˜ื™ื ื›ื•ืœืœ ืคืจืงื™ื, ื’ืจืคื™ืงื” ื•ืชื™ืื•ืจื™ ืคื•ื“ืงืืกื˜ื™ื ืžื•ืขืœื™ื ื•ืžืกื•ืคืงื™ื ื™ืฉื™ืจื•ืช ืขืœ ื™ื“ื™ Flot.bio ืื• ืฉื•ืชืฃ ืคืœื˜ืคื•ืจืžืช ื”ืคื•ื“ืงืืกื˜ ืฉืœื”ื. ืื ืืชื” ืžืืžื™ืŸ ืฉืžื™ืฉื”ื• ืžืฉืชืžืฉ ื‘ื™ืฆื™ืจื” ืฉืœืš ื”ืžื•ื’ื ืช ื‘ื–ื›ื•ื™ื•ืช ื™ื•ืฆืจื™ื ืœืœื ืจืฉื•ืชืš, ืืชื” ื™ื›ื•ืœ ืœืขืงื•ื‘ ืื—ืจ ื”ืชื”ืœื™ืš ื”ืžืชื•ืืจ ื›ืืŸ https://he.player.fm/legal.

Weโ€™re in San Sebastiรกn ๐Ÿ‡ช๐Ÿ‡ธ with one of the top VCs in Europe, Christina Takke from V-Bio Ventures.

We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 2022.

๐Ÿ’Ž ABOUT THE SPEAKER

Christina co-founded V-Bio Ventures in 2015 and is now the Managing Partner. Before this, she was a leader in the European Venture Capital world with 15 years of experience. She has been a partner at Forbion Capital Partners where she led many successful investments in biopharma and pharma companies.

๐Ÿ”— LINKS MENTIONED

- Lean years for company creation in Europe? - BioVox, Sep 2023 - https://biovox.eu/lean-years-for-company-creation-in-europe/

๐Ÿ“œ TRANSCRIPT

Read the full transcript here: https://flot.bio/episode/christina-takke-v-bio-ventures/

๐Ÿ’ธ DONATE

We welcome donations from individuals and businesses to support our more content creation: https://www.paypal.me/PhilipHemmeโญ๏ธ

SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!

๐Ÿซถ FOLLOW US

- Newsletter: http://eepurl.com/h_fnmH

- LinkedIn: https://www.linkedin.com/company/flot-bio/

- X (Twitter): https://x.com/FlotBio

๐Ÿ™ LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.

๐ŸŽ™๏ธ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.

โฐ TIMESTAMPS

[00:00:00] Intro

[00:02:03] Top VC woman in biotech

[00:08:36] European background

[00:13:49] Investing in Argenx at the start

[00:20:26] V-Bio story

[00:25:09] Tech transfer

[00:35:44] Company creation drop

[00:42:39] Thanks for listening

  continue reading

24 ืคืจืงื™ื

ื›ืœ ื”ืคืจืงื™ื

×
 
Loading …

ื‘ืจื•ื›ื™ื ื”ื‘ืื™ื ืืœ Player FM!

Player FM ืกื•ืจืง ืืช ื”ืื™ื ื˜ืจื ื˜ ืขื‘ื•ืจ ืคื•ื“ืงืืกื˜ื™ื ื‘ืื™ื›ื•ืช ื’ื‘ื•ื”ื” ื‘ืฉื‘ื™ืœื›ื ื›ื“ื™ ืฉืชื”ื ื• ืžื”ื ื›ืจื’ืข. ื–ื” ื™ื™ืฉื•ื ื”ืคื•ื“ืงืืกื˜ ื”ื˜ื•ื‘ ื‘ื™ื•ืชืจ ื•ื”ื•ื ืขื•ื‘ื“ ืขืœ ืื ื“ืจื•ืื™ื“, iPhone ื•ืื™ื ื˜ืจื ื˜. ื”ื™ืจืฉืžื• ืœืกื ื›ืจื•ืŸ ืžื ื•ื™ื™ื ื‘ืžื›ืฉื™ืจื™ื ืฉื•ื ื™ื.

 

ืžื“ืจื™ืš ืขื–ืจ ืžื”ื™ืจ

ืคื•ื“ืงืืกื˜ื™ื ืžื•ื‘ื™ืœื™ื